Generic Times Product News

SEPTEMBER 01, 2007

Amlodipine Besylate Tablets

Marketed by: Teva Pharmaceuticals USA (North Wales, Pa)

Compared to: Norvasc Tablets (Pfizer Inc)

Indication: July 10, 2007?Teva Pharmaceuticals announced the introduction and availability of Amlodipine Besylate Tablets. These tablets are indicated for the treatment of hypertension (used alone or in combination with other antihypertensive agents); chronic stable angina (used alone or in combination with other antianginal drugs); and confirmed or suspected vasospastic angina (Prinzmetal?s or variant angina; used as monotherapy or in combination with other antianginal drugs). These tablets are available in 2.5-, 5-, and 10-mg strengths in bottles of 90 tablets and in 5-mg strength in bottles of 300 tablets.

Dosage Form: Tablets: 2.5, 5, and 10 mg

For More Information: 888-TEVA USA (888-838-2872)

Atenolol Tablets USP

Marketed by: Caraco Pharmaceutical Laboratories Ltd (Detroit, Mich)

Compared to: Tenormin (AstraZeneca Pharmaceuticals LP)

Indication: July 11, 2007?Caraco Pharmaceutical Laboratories announced that the FDA granted final approval for its abbreviated new drug application for Atenolol Tablets USP. Atenolol Tablets are indicated in the management of hypertension, the long-term management of patients with angina pectoris, and the management of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. These tablets are available in 3 strengths: 25, 50, and 100 mg.

Dosage Form: Tablets: 25, 50, and 100 mg

For More Information:

Loratadine Orally Disintegrating Tablets

Marketed by: Ohm Laboratories Inc (Princeton, NJ), a wholly owned subsidiary of Ranbaxy Laboratories Ltd (RLL)

Compared to: Claritin Reditabs (Schering-Plough Healthcare Products)

Indication: April 12, 2007?Ohm Laboratories announced that RLL received FDA approval to manufacture and market its Loratadine Orally Disintegrating Tablets, 10 mg. This long-acting antihistamine agent is indicated for the temporary relief of runny nose; sneezing; itching of the nose or throat; and itchy, watery eyes due to hay fever or other respiratory allergies in adults and children aged 6 years and older.

Dosage Form: Tablets: 10 mg

For More Information:

Metoprolol Succinate Extended-release Tablets

Marketed by: KV Pharmaceutical Co (St. Louis, Mo)

Compared to: Toprol-XL (AstraZeneca Pharmaceuticals LP)

Indication: July 26, 2007?KV Pharmaceutical Co announced the launch of its 100- and 200-mg strengths of metoprolol succinate extended-release tablets. These tablets are indicated for the treatment of hypertension (used alone or in combination with other antihypertensive agents); the long-term management of angina pectoris; and the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin.

Dosage Form: Tablets: 100 and 200 mg

For More Information:

Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Personalize the information you receive by selecting targeted content and special offers.